Two Schemes Response in Multiple Myeloma
Retrospective study based on medical records of patients with multiple myeloma, eligible for stem cell transplantation, who received, first-line, the VTD or TD combination.
| Condition(s) | Response, Acute Phase, Survivorship |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Retrospective study based on medical records of patients with multiple myeloma, eligible for stem cell transplantation, who received, first-line, the VTD or TD combination. |
| Who can participate | Inclusion Criteria: * clinical records of patients who were considered eligible for transplant due to their functional status and who were given some treatment strategy comprising a combination of drugs. Exclusion Criteria: * Incomplete clinical records * Clinical records of patients who abandoned treatment or could not continue with the treatment due to economic or distance issues * Clinical records of patients who presented severe sepsis before the beginning of either treatment |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Lead sponsor | Hospital General de Mexico |
| Locations | Mexico City, Mexico City, Mexico |
| Start date | 2023-11-20 |
| NCT ID | NCT06284395 |
| Official listing | https://clinicaltrials.gov/study/NCT06284395 |